Welcome to our dedicated page for Arteris SEC filings (Ticker: AIP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Arteris, Inc. filings document a semiconductor technology business built around System IP for SoC and chiplet design. Its 8-K reports cover quarterly and annual operating results, financial-condition updates, guidance exhibits, customer shipment milestones, royalty trends and product portfolio disclosures for network-on-chip interconnect IP, SoC integration automation software and hardware security assurance.
The company’s proxy materials cover board elections, executive compensation, equity incentive arrangements and stockholder voting matters. They also describe governance and business context for Arteris’ markets, including automotive, artificial intelligence and machine learning, 5G communications, data centers, edge computing, enterprise and consumer electronics.
Arteris, Inc. (AIP) Form 144 reports a proposed sale of 3,660 common shares with an aggregate market value of $31,439.40, scheduled approximately for 09/09/2025 through NASDAQ by broker Morgan Stanley Smith Barney LLC. The shares were acquired as Restricted Stock Units from the issuer on 04/01/2025. The filing lists prior sales by the same person, Nicholas Hawkins, including multiple 10b5-1 plan transactions from 06/25/2025 through 09/02/2025 totaling several tens of thousands of shares and proceeds shown per trade.
Janac K Charles, President and CEO of Arteris, Inc. (AIP) and a director with 10% ownership, reported a planned sale of common stock executed on 09/04/2025 under a 10b5-1 trading plan adopted March 5, 2025. The reported transaction shows 2,057 shares sold at a weighted average price of $8.7255, with individual sale prices ranging from $8.5750 to $8.8900.
Following the sale, the reporting person beneficially owns 186,482 shares directly and indirectly holds 9,839,071 shares through Bayview Legacy, LLC and 56,252 shares through the Charles and Lydia Janac Trust. The filer provided the standard footnote offering to supply detailed per-price sale information on request.
Arteris, Inc. (AIP) Form 144: An insider intends to sell 424 shares of common stock through Morgan Stanley Smith Barney, scheduled approximately 09/08/2025, with an aggregate market value reported as $3,756.64. The filing reports those 424 shares were acquired as restricted stock units on 09/01/2025. The filing also discloses prior dispositions by the same person during the past three months: 258 shares on 09/02/2025 (gross proceeds $2,306.96) and two July sales totaling 6,488 shares (gross proceeds $59,259.89), including a 10b5-1 plan sale of 3,609 shares on 07/03/2025. The filer certifies no undisclosed material information.
Arteris, Inc. (AIP) filed a Form 144 reporting a planned sale of 12,978 common shares valued at $114,725.52, representing part of ~42.65 million shares outstanding, with an approximate sale date of 09/05/2025 on NASDAQ. The shares were acquired as restricted stock units on 09/01/2025 and are scheduled for sale the same month. The filing also discloses sales by Laurent Moll totaling 84,380 shares for aggregate gross proceeds of $915,838.75 over the past three months, including transactions executed under a 10b5-1 plan. The filer certifies no undisclosed material adverse information.
Arteris, Inc. (AIP) Form 4 summary: On 09/03/2025 the reporting person, Wayne C. Cantwell, filed changes in beneficial ownership showing related transfers of 228,198 shares of Arteris common stock. The Form records a 228,198 share disposition (code G(1)) reported at $0.00, and a corresponding 228,198 acquisition (code G) at $0.00 that is held indirectly by The Cantwell Living Trust. After the reported transactions, the filing shows 34,732 shares beneficially owned directly, 228,198 shares indirectly via The Cantwell Living Trust, and 38,761 shares indirectly by the Decathlon Capital Management 401K Plan FBO Wayne Cantwell. The form is signed by an attorney-in-fact on 09/04/2025.
Arteris, Inc. (AIP) submitted a Form 144 notifying the proposed sale of 2,057 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $18,163.31 and an approximate sale date of 09/04/2025. The shares were acquired as Restricted Stock Units on 09/01/2025. The filing also discloses multiple sales by the same account and related parties over the prior three months, including large 10b5-1 planned sales on 08/05/2025 and other dates. The filer attests there is no undisclosed material adverse information.
Arteris, Inc. (AIP) insider Moll Laurent R, Chief Operating Officer and director, reported stock dispositions on 09/02/2025. The Form 4 shows three sales executed at $8.9417 per share: 868 shares, 17,264 shares and 24,560 shares. The filings show remaining beneficial ownership after each sale of 441,203; 423,939; and 399,379 shares, respectively. The Form states the shares were sold to satisfy the reporting person’s tax liability arising from the release of restricted stock units.
The Form 4 was signed by an attorney-in-fact on 09/03/2025. The disclosure documents the officer’s routine tax-related stock withholding and satisfies Section 16 reporting obligations.
Janac K. Charles, who serves as President and CEO, a director and a >10% owner of Arteris, Inc. (AIP), reported a sale of 1,246 shares of common stock on 09/02/2025 at a price of $8.9417 per share to satisfy the reporting person’s tax liability arising from the release of restricted stock units. After the transaction, the filing shows 188,539 shares beneficially owned directly by the reporting person, plus 9,839,071 shares indirectly held by Bayview Legacy, LLC and 56,252 shares indirectly held by the Charles and Lydia Janac Trust. The filer is the manager of Bayview Legacy, LLC and trustee of the trust. The Form 4 was signed by an attorney-in-fact on 09/03/2025.
Arteris, Inc. (AIP) Form 4: Nicholas B. Hawkins, Vice President and Chief Financial Officer, reported a sale of 438 shares of Arteris common stock on 09/02/2025 at a price of $8.9417 per share. The filing states the shares were sold to satisfy the reporting person’s tax liability arising from the release of restricted stock units. After the transaction Hawkins beneficially owned 107,558 shares, held directly. The form was signed by an attorney-in-fact on behalf of Hawkins on 09/03/2025.
Arteris, Inc. (AIP) reporting person Paul L. Alpern, VP and General Counsel, disclosed a routine sale of common stock on 09/02/2025. The Form 4 shows 258 shares sold at $8.9417 per share under transaction code S(1), with the filing explaining the shares were sold to satisfy the reporting person’s tax liability arising from the release of restricted stock units. Following the sale, Mr. Alpern beneficially owns 76,289 shares directly. The form is signed by Paul Alpern on 09/03/2025 and indicates a single reporting person filing.